跳至主要内容
临床试验/NCT07062172
NCT07062172招募中不适用

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

University of California, Irvine1 个研究点 分布在 1 个国家目标入组 1,753 人开始时间: 2025年5月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
1,753
试验地点
1
主要终点
Number of lung cancers found

研究概览

简要总结

This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and screened using a low dose CT scan.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Inclusion Criteria:
  • •Current diagnosis of lung cancer with a driver mutation.
  • •Known driver mutation (e.g. via NGS, PCR, IHC, FISH, RT-PCR etc.)
  • •Able and willing to give informed consent.
  • •Able and willing to complete the screening questionnaire.

排除标准

  • •There are no exclusion criteria for Cohort A.
  • •Inclusion Criteria:
  • •Must have a first degree relative (mother, father, sibling, biological child) eligible for Cohort A. Note: Multiple first degree relatives of a Cohort A eligible participant may be approached for participation into the trial.
  • •Smoked < 20 pack years; a. Pack years = numbers of packs per day × number of years smoked; b. One pack year is the equivalent of smoking an average of 20 cigarettes (1 pack) per day for a year.
  • •Be able to undergo a low dose chest CT scan.
  • •If an upper respiratory infection (pneumonia, COVID19, flu, etc.) occurred in the last 3 months, this infection must have resolved by time of enrollment.
  • •Able and willing to provide informed consent.
  • •Able and willing to comply with the protocol requirements
  • •Exclusion Criteria:
  • •Previous history of lung cancers.
  • •Symptoms suggestive of presence of current lung cancer, including (but not limited to): unexplained weight loss of over 15 pounds within the last 12 months or unexplained hemoptysis.
  • •Pregnant at time of enrollment.
  • •History of any type of cancer within 5 years, with the exception of in situ carcinomas and non-melanoma skin cancers (if excised).
  • •Current smoker.
  • •Smoked ≥ 20 pack years.
  • •Had a chest CT scan within 1 year of study entry.

研究组 & 干预措施

Low Dose CT Scan of First Degree Relatives of Lung Cancer Patients

Experimental

First degree relatives of patients with lung cancer with a known driver mutation will receive a low dose CT scan of the chest to screen for lung abnormality.

干预措施: Low Dose CT Scan (Diagnostic Test)

结局指标

主要结局

Number of lung cancers found

时间窗: 2 years

Determine the number of lung cancers found in low dose CT scans of first degree relatives of lung cancer patients with known driver mutations.

次要结局

  • Number of follow-up CT scans(2 years)
  • Number of lung abnormalities detected(2 years)
  • Number and type of biopsies performed(2 years)
  • Number and type of resections performed(2 years)
  • Number of Adverse Events related to study procedures and follow-up interventions(2 years)
  • Stage of Lung Cancers Found(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hari Keshava

HS Assistant Clinical Professor

University of California, Irvine

研究点 (1)

Loading locations...

相似试验